Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial

Efficacy and safety of Treamid in the rehabilitation of patients after COVID-19 pneumonia: a phase 2, randomized, double-blind, placebo-controlled trial

Abstract Background Many patients who recovered from COVID are still suffering from pulmonary dysfunction that can be persistent even for months after infection. Therefore, treatment to prevent irreversible impairment of lung function is needed. Treamid (bisamide derivative of dicarboxylic acid, BDD...

Full description

Bibliographic Details
Main Authors: Evgeny Bazdyrev, Maria Panova, Maria Brachs, Elena Smolyarchuk, Daria Tsygankova, Liudmila Gofman, Yana Abdyusheva, Fedor Novikov
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Journal of Translational Medicine
Subjects:
COVID
SARS-CoV-2
Post-COVID rehabilitation
Lung function
Lung fibrosis
Treamid
Online Access:https://doi.org/10.1186/s12967-022-03660-9

Internet

https://doi.org/10.1186/s12967-022-03660-9

Similar Items